Trevi Therapeutics Stock (NASDAQ: TRVI) stock price, news, charts, stock research, profile.
You can purchase shares of Trevi Therapeutics (NASDAQ:TRVI) through any online brokerage.
Other companies in Trevi Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH) and GH Research (NASDAQ:GHRS).
Trevi Therapeutics has a consensus price target of $9.88.
The stock price for Trevi Therapeutics (NASDAQ: TRVI) is $4.03 last updated January 8, 2025 at 4:00 PM EST.
There are no upcoming dividends for Trevi Therapeutics.
Trevi Therapeutics’s Q4 earnings are confirmed for Wednesday, March 19, 2025.
There is no upcoming split for Trevi Therapeutics.
Trevi Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.